APOBEC3B deletion and risk of HIV-1 acquisition

Six challenges in acute pain trials and one differentiator—coordinated execution We’ve all been there before. Your acute

Acute pain trials start with assumptions. How you execute—when reality sets in—determines the outcome. When you’re designing

Early in clinical development, it’s easy to focus on what’s directly in front of you. After all,

Early clinical decisions shape regulatory risk and the path to approval   Assumptions about study design and